FDA Clearance Tracker · P100045-S018
CARDIOMEMS HF SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 14, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Feb 14, 2017
Approved
Time to decision
61 days
Received Dec 15, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100045-S018
- Device name
- CARDIOMEMS HF SYSTEM
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Atlanta, GA
- Received
- Dec 15, 2016
- Decided
- Feb 14, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P100045
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for changes to the protocol, such as Quality of Life evaluations as well as minor clarifications for the post-approval study (PAS) protocol.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.